U.S. Physical Therapy (USPH) Scheduled to Post Quarterly Earnings on Tuesday

U.S. Physical Therapy (NYSE:USPH) is scheduled to be announcing its earnings results after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.58 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Wednesday, February 28th. The company reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.57 by $0.02. The business had revenue of $154.80 million during the quarter, compared to the consensus estimate of $150.24 million. U.S. Physical Therapy had a return on equity of 8.52% and a net margin of 4.67%. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.58 earnings per share. On average, analysts expect U.S. Physical Therapy to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

U.S. Physical Therapy Stock Performance

USPH traded down $0.56 during midday trading on Tuesday, hitting $101.42. 5,648 shares of the company traded hands, compared to its average volume of 68,717. The company’s 50-day moving average is $105.03 and its 200 day moving average is $95.64. The company has a quick ratio of 2.28, a current ratio of 2.28 and a debt-to-equity ratio of 0.29. The firm has a market capitalization of $1.53 billion, a PE ratio of 75.54, a price-to-earnings-growth ratio of 4.77 and a beta of 1.39. U.S. Physical Therapy has a 52 week low of $78.08 and a 52 week high of $124.11.

U.S. Physical Therapy Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 5th. Stockholders of record on Tuesday, March 12th were paid a $0.44 dividend. The ex-dividend date was Monday, March 11th. This represents a $1.76 annualized dividend and a dividend yield of 1.74%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. U.S. Physical Therapy’s dividend payout ratio is currently 130.37%.

Insider Activity

In related news, Director Edward L. Kuntz sold 2,500 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $104.26, for a total value of $260,650.00. Following the transaction, the director now directly owns 5,780 shares in the company, valued at $602,622.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CFO Carey P. Hendrickson sold 1,800 shares of the stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total transaction of $193,104.00. Following the transaction, the chief financial officer now owns 21,186 shares of the company’s stock, valued at approximately $2,272,834.08. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Edward L. Kuntz sold 2,500 shares of the firm’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $104.26, for a total transaction of $260,650.00. Following the completion of the sale, the director now owns 5,780 shares of the company’s stock, valued at $602,622.80. The disclosure for this sale can be found here. In the last quarter, insiders have sold 10,829 shares of company stock valued at $1,141,535. 1.80% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several analysts have weighed in on USPH shares. JPMorgan Chase & Co. boosted their target price on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research report on Wednesday, March 13th. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Monday, March 18th. Finally, Barrington Research raised their target price on shares of U.S. Physical Therapy from $120.00 to $122.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $125.67.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.